The Senores Pharmaceuticals IPO is a book-built issue worth ₹582.11 crores, comprising a fresh issue of 1.28 crore shares aggregating to ₹500.00 crores and an offer for sale of 0.21 crore shares aggregating to ₹82.11 crores.
The IPO opens for subscription on December 20, 2024, and closes on December 24, 2024. The allotment is expected to be finalized on Thursday, December 26, 2024, with a tentative listing date of Monday, December 30, 2024, on the BSE and NSE.
The price band for the IPO is ₹372 to ₹391 per share, with a minimum lot size of 38 shares.
- Retail Investors: Minimum investment is ₹14,858.
- sNII: Minimum investment is ₹2,08,012 (14 lots, 532 shares).
- bNII: Minimum investment is ₹10,10,344 (68 lots, 2,584 shares).
For detailed information about the Senores Pharmaceuticals IPO RHP, please refer to the Red Herring Prospectus (RHP). The RHP provides comprehensive details about the company’s financials, business operations, risks, and other critical aspects of the IPO.
Senores Pharmaceuticals IPO Details
IPO Date | December 20, 2024 to December 24, 2024 |
Face Value | ₹10 per share |
Price Band | ₹372 to ₹391 per share |
Lot Size | 38 Shares |
Total Issue Size | 1,48,87,723 shares (aggregating up to ₹582.11 Cr) |
Fresh Issue | 1,27,87,723 shares (aggregating up to ₹ 500.00 Cr) |
Offer for Sale | 21,00,000 shares of ₹10 (aggregating up to ₹82.11 Cr) |
Issue Type | Book Built Issue IPO |
Listing At | BSE, NSE |
Share Holding Pre Issue | 3,32,65,865 shares |
Share Holding Post Issue | 4,60,53,588 shares |
Senores Pharmaceuticals IPO Timeline
The Senores Pharmaceuticals IPO opens on December 20, 2024, and closes on December 24, 2024.
IPO Open Date | Friday, December 20, 2024 |
IPO Close Date | Tuesday, December 24, 2024 |
Basis of Allotment | Thursday, December 26, 2024 |
Initiation of Refunds | Friday, December 27, 2024 |
Credit of Shares to Demat | Friday, December 27, 2024 |
Listing Date | Monday, December 30, 2024 |
Senores Pharmaceuticals IPO Lot Size
Investors can bid for a minimum of 38 shares and in multiples thereof. The table below outlines the minimum and maximum investment for retail investors and HNIs in terms of shares and amounts:
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 38 | ₹14,858 |
Retail (Max) | 13 | 494 | ₹1,93,154 |
S-HNI (Min) | 14 | 532 | ₹2,08,012 |
S-HNI (Max) | 67 | 2,546 | ₹9,95,486 |
B-HNI (Min) | 68 | 2,584 | ₹10,10,344 |
Senores Pharmaceuticals IPO Reservation
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | 66,65,725 (45%) | NA |
QIB Shares Offered | 44,43,817 (30%) | NA |
NII (HNI) Shares Offered | 22,21,909 (15%) | |
bNII > ₹10L | 15,18,605 (10.25%) | 2,854 |
sNII < ₹10L | 7,03,304 (4.75%) | 1,322 |
Retail Shares Offered | 14,81,272 (10%) | 38,980 |
Total Shares Offered | 1,48,12,723 (100%) |
About Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited, incorporated in December 2017, develops and manufactures a wide range of pharmaceutical products for regulated markets such as the US, Canada, and the UK, as well as for emerging markets.
The company’s product portfolio includes Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, and several other critical medicines for regulated markets. As of September 30, 2024, it has launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments, and has built partnerships with distributors and hospitals across India.
The company operates three R&D facilities located in India and the US and manufactures critical care injectables and APIs. Its manufacturing unit is situated in Ahmedabad, Gujarat, and the company has a presence in 43 countries within emerging markets.
Senores Pharmaceuticals IPO FAQs
What is the Senores Pharmaceuticals IPO?
The Senores Pharmaceuticals IPO is a main-board issue of 14,887,723 equity shares with a face value of ₹10, aggregating up to ₹582.11 crores. The price band is set at ₹372 to ₹391 per share, and the minimum order quantity is 38 shares.
The IPO will open on December 20, 2024, and close on December 24, 2024.
Link Intime India Private Ltd is the registrar for the IPO, and the shares are proposed to be listed on BSE and NSE.
When Senores Pharmaceuticals IPO will open?
The Senores Pharmaceuticals IPO opens on December 20, 2024, and closes on December 24, 2024.
What is the lot size of Senores Pharmaceuticals IPO?
The Senores Pharmaceuticals IPO has a lot size of 38 shares, and the minimum investment amount required is ₹14,858.
When is Senores Pharmaceuticals IPO allotment?
The finalization of the Basis of Allotment for the Senores Pharmaceuticals IPO will be completed on Thursday, December 26, 2024, and the allotted shares will be credited to your demat account by Friday, December 27, 2024.
When is Senores Pharmaceuticals IPO listing date?
The **Senores Pharmaceuticals IPO** listing date is **Monday, December 30, 2024**.